pT2/shp53/GFP4 Citations (3)

Originally described in: De novo induction of genetically engineered brain tumors in mice using plasmid DNA.
Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR Cancer Res. 2009 Jan 15. 69(2):431-9. PubMed Journal

---

Articles Citing pT2/shp53/GFP4

Articles
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence. Cheng Y, Wang S, Zhang H, Lee JS, Ni C, Guo J, Chen E, Wang S, Acharya A, Chang TC, Buszczak M, Zhu H, Mendell JT. Cell. 2024 Aug 22;187(17):4770-4789.e23. doi: 10.1016/j.cell.2024.06.019. Epub 2024 Jul 8. PubMed
Nuclear-localized HKDC1 promotes hepatocellular carcinoma through phosphorylating RBBP5 to upregulate H3K4me3. Ye L, Shen S, Mao Q, Lu H, Liu H, Zhang P, Jiang Z, Ma W, Sun Y, Chu Y, Zhou Z, Liu R, Li J, Li ST, Gao P, Zhang H. Cell Rep. 2025 Feb 25;44(2):115250. doi: 10.1016/j.celrep.2025.115250. Epub 2025 Jan 31. PubMed
Chemoprevention of hepatocellular carcinoma using N-acetylgalactosamine-conjugated siRNAs. Maggiore G, Hsieh MH, Bellary A, Gopal P, Li L, Guo J, Hsiehchen D, Dadali T, Broom W, Maier M, Zhu H. Dis Model Mech. 2025 Aug 1;18(8):dmm052370. doi: 10.1242/dmm.052370. Epub 2025 Sep 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.